Tomioka-Inagawa, R., Nakane, K., Enomoto, T., Tomioka, M., Taniguchi, T., Ishida, T., . . . Koie, T. (2022, July). The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma. Biomedicines.
Chicago Style (17th ed.) CitationTomioka-Inagawa, Risa, et al. "The Impact of Neutrophil-to-Lymphocyte Ratio After Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma." Biomedicines Jul. 2022.
MLA (9th ed.) CitationTomioka-Inagawa, Risa, et al. "The Impact of Neutrophil-to-Lymphocyte Ratio After Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma." Biomedicines, Jul. 2022.
Warning: These citations may not always be 100% accurate.